Anocca

Company Description

Anocca is a Swedish biotech company with a primary focus on oncology TCR-T development. We have over the past 10 years developed end-to-end capabilities for precise and highly scalable TCR-T cell therapy deployment. With over 40+ TCR assets in pipeline, Anocca’s first clinical trial will launch in Q1 2025.